Erythropoietin: Physiology and Pharmacology Update
Indexed incrossrefdoajpubmed
Abstract
This minireview is an update of a 1997 review on erythropoietin (EPO) in this journal. EPO is a 30,400-dalton glycoprotein that regulates red cell production. In the human, EPO is produced by peritubular cells in the kidneys of the adult and in hepatocytes in the fetus. Small amounts of extra-renal EPO are produced by the liver in adult human subjects. EPO binds to an erythroid progenitor cell surface receptor that includes a p66 chain, and, when activated, the p66 protein becomes dimerized. EPO receptor activation induces a JAK2 tyrosine kinase, which leads to tyrosine phosphorylation of the EPO receptor and several proteins. EPO receptor binding leads to intracellular activation of the Ras/mitogen-activated…
Citation impact
705
total citations
- FWCI
- 16.80
- Percentile
- 100%
- References
- 190
Citations per year
Authors
1Topics & keywords
Topics
Keywords
- Erythropoietin
- Erythropoietin receptor
- Biology
- Cell biology
- CREB
- Receptor tyrosine kinase
- Signal transduction
- Kinase
No related works found for this paper.